Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 4Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Vomiting 2Uterine Cervical Neoplasms 1Neoplasms 1Nausea 1Lung Neoplasms 1

Interventions

Dexamethasone 11Aprepitant 8Olanzapine 5ramosetron 4Palonosetron 4fosaprepitant 3Ondansetron 3Granisetron 3netupitant, palosentron drug combination 2Tropisetron 2Calcium Dobesilate 2netupitant 1lerisetron 1dexamethasone 21-phosphate 1Transcranial Direct Current Stimulation 1Tablets 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy 1Paclitaxel 1Music Therapy 1Metoclopramide 1Megestrol Acetate 1Megestrol 1Gelatin 1Dronabinol 1Dosage Forms 1Carboplatin 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Vomiting × netupitant, palosentron drug combination × Clear all
NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Odense University Hospital

Phase 2/3 Unknown
80 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vomiting

NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡